Duke Street Bio receives FDA Fast Track designation for PARP1-Selective Inhibitor DSB2455 in patients with HRD brain metastases from triple-negative breast cancer
June 16, 2025
June 16, 2025
June 11, 2025
January 8, 2025
January 8, 2025
December 16, 2024
December 9, 2024
December 4, 2024
November 27, 2024
November 19, 2024
June 24, 2025
Alithea Genomics, a pioneering biotech company based in Switzerland and the USA specializing in high-throughput RNA sequencing solutions, today announ...
June 19, 2025
Alithea Genomics, a pioneering biotech company based in Switzerland and the USA specializing in scalable RNA sequencing solutions, today announced the...
June 16, 2025
Fast Track granted for a next-generation, PARP1-selective inhibitor with CNS activity Addresses brain metastases harboring BRCA1/2 and/or HRR alterati...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225